• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析是胆总管结石患者内镜下括约肌切开术后出血的一个重要危险因素。

Hemodialysis is a strong risk factor for post-endoscopic sphincterotomy bleeding in patients with choledocholithiasis.

作者信息

Nakaji So, Hirata Nobuto, Matsui Hiroki, Shiratori Toshiyasu, Kobayashi Masayoshi, Yoshimura Shigenobu, Kanda Keisuke, Kawamitsu Natsuki, Harasawa Hisato

机构信息

Department of Gastroenterology, Kameda Medical Center, Kamogawa City, Japan.

Clinical Research Support Division, Kameda Institute for Health Science, Kameda College of Health Sciences, Kamogawa City, Japan.

出版信息

Endosc Int Open. 2018 May;6(5):E568-E574. doi: 10.1055/a-0587-4470. Epub 2018 May 8.

DOI:10.1055/a-0587-4470
PMID:29756014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5943695/
Abstract

BACKGROUND AND STUDY AIMS

Hemodialysis (HD) is considered one of the risk factors for post-endoscopic sphincterotomy (ES) bleeding. Therefore, we conducted a retrospective study to evaluate HD as a risk factor for post-ES bleeding in patients with choledocholithiasis.

PATIENTS AND METHODS

We used the post-ES bleeding rate as the main outcome measure. To evaluate the influence of HD on the risk of post-ES bleeding, logistic regression and propensity score analyses were conducted. In addition, univariate analysis-based comparisons of various clinical parameters (as secondary outcome measures) were performed between the patients in the HD and non-HD groups that experienced post-ES bleeding.

RESULTS

A total of 1518 patients were enrolled. In the multivariate analysis, a platelet count of < 50,000, anticoagulant therapy, bleeding during ES, and HD were found to be significantly associated with post-ES bleeding (odds ratio [OR]: 35.30, 95 % confidence interval [CI]: 3.81 - 328.00; OR: 4.39, 95 % CI: 1.53 - 12.60; OR: 4.28, 95 % CI: 2.30 - 7.97; and OR: 13.30, 95 % CI: 5.78 - 30.80, respectively). Propensity score matching created 28 matched pairs. Propensity score analysis showed that the risk difference between the groups was 0.214 (95 % CI: 0.022 - 0.407). In a comparison between the patients in the HD and non-HD groups that suffered post-ES bleeding, it was found that the post-ES bleeding was significantly more severe in the HD group (p = 0.033), and massive blood transfusions and long periods of hospitalization were more frequently required in the HD group (p = 0.008 and p < 0.001, respectively).

CONCLUSION

HD is an independent risk factor for post-ES bleeding and makes post-ES bleeding more serious.

摘要

背景与研究目的

血液透析(HD)被认为是内镜下括约肌切开术(ES)后出血的危险因素之一。因此,我们进行了一项回顾性研究,以评估HD作为胆总管结石患者ES后出血的危险因素。

患者与方法

我们将ES后出血率作为主要结局指标。为评估HD对ES后出血风险的影响,进行了逻辑回归和倾向评分分析。此外,对发生ES后出血的HD组和非HD组患者的各种临床参数(作为次要结局指标)进行基于单因素分析的比较。

结果

共纳入1518例患者。多因素分析发现,血小板计数<50,000、抗凝治疗、ES期间出血和HD与ES后出血显著相关(比值比[OR]:35.30,95%置信区间[CI]:3.81 - 328.00;OR:4.39,95% CI:1.53 - 12.60;OR:4.28,95% CI:2.30 - 7.97;以及OR:13.30,95% CI:5.78 - 30.80)。倾向评分匹配产生了28对匹配对。倾向评分分析显示,两组之间的风险差异为0.214(95% CI:0. 022 - 0.407)。在发生ES后出血的HD组和非HD组患者的比较中,发现HD组的ES后出血明显更严重(p = 0.033),HD组更频繁地需要大量输血和长时间住院(分别为p = 0.008和p < 0.001)。

结论

HD是ES后出血的独立危险因素,并使ES后出血更严重。

相似文献

1
Hemodialysis is a strong risk factor for post-endoscopic sphincterotomy bleeding in patients with choledocholithiasis.血液透析是胆总管结石患者内镜下括约肌切开术后出血的一个重要危险因素。
Endosc Int Open. 2018 May;6(5):E568-E574. doi: 10.1055/a-0587-4470. Epub 2018 May 8.
2
Predictive model of bleeding following endoscopic sphincterotomy for the treatment of choledocholithiasis in hemodialysis patients: A retrospective multicenter study.血液透析患者内镜下括约肌切开术治疗胆总管结石后出血的预测模型:一项回顾性多中心研究。
JGH Open. 2020 May 17;4(5):915-922. doi: 10.1002/jgh3.12363. eCollection 2020 Oct.
3
Prophylactic use of a self-assembling peptide hydrogel for preventing delayed bleeding after endoscopic sphincterotomy: A propensity score-matched analysis.预防性应用自组装肽水凝胶预防内镜下括约肌切开术后迟发性出血的效果:倾向评分匹配分析。
J Gastroenterol Hepatol. 2024 Oct;39(10):2129-2135. doi: 10.1111/jgh.16642. Epub 2024 Jun 5.
4
Risk factor of bleeding after endoscopic sphincterotomy in average risk patients.一般风险患者内镜下括约肌切开术后出血的风险因素。
Surg Endosc. 2019 Oct;33(10):3334-3340. doi: 10.1007/s00464-018-06623-8. Epub 2019 Jan 2.
5
Comparison of late adverse events after endoscopic sphincterotomy versus endoscopic papillary large balloon dilation for common bile duct stones: A propensity score-based cohort analysis.内镜下括约肌切开术与内镜下乳头大球囊扩张术治疗胆总管结石后晚期不良事件的比较:基于倾向评分的队列分析。
Dig Endosc. 2018 Jul;30(4):493-500. doi: 10.1111/den.13031. Epub 2018 Feb 27.
6
Predictors of re-bleeding after endoscopic hemostasis for delayed post-endoscopic sphincterotomy bleeding.内镜下括约肌切开术后延迟出血内镜止血后再出血的预测因素。
World J Gastroenterol. 2016 Mar 21;22(11):3196-201. doi: 10.3748/wjg.v22.i11.3196.
7
Early Covered Self-Expandable Metal Stent Placement Is Effective for Massive Post-endoscopic Sphincterotomy Bleeding.早期覆膜自膨式金属支架置入术治疗内镜下括约肌切开术后大出血有效。
Dig Dis Sci. 2020 Nov;65(11):3324-3331. doi: 10.1007/s10620-020-06057-0. Epub 2020 Jan 16.
8
The Impact of Cholecystectomy After Endoscopic Sphincterotomy for Complicated Gallstone Disease.内镜括约肌切开术后胆囊切除术对复杂性胆结石疾病的影响。
Am J Gastroenterol. 2017 Oct;112(10):1596-1602. doi: 10.1038/ajg.2017.247. Epub 2017 Aug 15.
9
The impact of selective serotonin receptor inhibitors on post-endoscopic sphincterotomy bleeding, alone or with concurrent aspirin or nonsteroidal anti-inflammatory drugs.选择性5-羟色胺再摄取抑制剂对内镜下括约肌切开术后出血的影响,单独使用或与阿司匹林或非甾体抗炎药同时使用时的情况。
Ann Gastroenterol. 2019 Nov-Dec;32(6):614-619. doi: 10.20524/aog.2019.0425. Epub 2019 Oct 8.
10
Effect of sustained use of platelet aggregation inhibitors on post-endoscopic sphincterotomy bleeding.血小板聚集抑制剂持续使用对内镜下括约肌切开术后出血的影响。
Dig Endosc. 2014 Nov;26(6):737-44. doi: 10.1111/den.12271. Epub 2014 Mar 27.

引用本文的文献

1
Impact of atrial fibrillation on in-hospital outcomes following endoscopic retrograde cholangiopancreatography: a propensity score-matched analysis of the National Inpatient Sample (2016-2020).心房颤动对内镜逆行胰胆管造影术后住院结局的影响:一项基于国家住院样本(2016 - 2020年)的倾向评分匹配分析
Ann Gastroenterol. 2025 May-Jun;38(3):345-352. doi: 10.20524/aog.2025.0964. Epub 2025 Apr 25.
2
Prediction and prevention of post-procedural bleedings in patients with cirrhosis.肝硬化患者术后出血的预测与预防
Clin Mol Hepatol. 2025 Feb;31(Suppl):S205-S227. doi: 10.3350/cmh.2024.0928. Epub 2025 Feb 18.
3
Post-endoscopic sphincterotomy delayed bleeding occurs in patients with just 1-day interruption of direct oral anticoagulants or hemodialysis.内镜下括约肌切开术后延迟出血发生在仅中断直接口服抗凝剂1天或进行血液透析的患者中。
DEN Open. 2025 Jan 16;5(1):e70060. doi: 10.1002/deo2.70060. eCollection 2025 Apr.
4
Factors Associated with the Severity of ERCP-Related Complications: A Retrospective Single-Centre Study.与内镜逆行胰胆管造影(ERCP)相关并发症严重程度相关的因素:一项回顾性单中心研究
J Clin Med. 2024 Dec 9;13(23):7481. doi: 10.3390/jcm13237481.
5
Risk of post-sphincterotomy bleeding in patients with thrombocytopenia.血小板减少症患者括约肌切开术后出血的风险
Ther Adv Gastrointest Endosc. 2023 Sep 25;16:26317745231200971. doi: 10.1177/26317745231200971. eCollection 2023 Jan-Dec.
6
Endoscopic retrograde cholangiopancreatography-related complications: risk stratification, prevention, and management.内镜逆行胰胆管造影术相关并发症:风险分层、预防及管理
Clin Endosc. 2023 Jul;56(4):433-445. doi: 10.5946/ce.2023.013. Epub 2023 Jul 17.
7
Outcomes of Endoscopic Retrograde Cholangiopancreatography in End-Stage Renal Disease Patients Undergoing Hemodialysis: A Systematic Review and Pooled Analysis.接受血液透析的终末期肾病患者内镜逆行胰胆管造影术的结果:一项系统评价和汇总分析
J Pers Med. 2022 Nov 10;12(11):1883. doi: 10.3390/jpm12111883.
8
Direct oral anticoagulants increase bleeding risk after endoscopic sphincterotomy: a retrospective study.直接口服抗凝剂增加内镜括约肌切开术后出血风险:一项回顾性研究。
BMC Gastroenterol. 2021 Oct 24;21(1):401. doi: 10.1186/s12876-021-01980-6.
9
Predictive model of bleeding following endoscopic sphincterotomy for the treatment of choledocholithiasis in hemodialysis patients: A retrospective multicenter study.血液透析患者内镜下括约肌切开术治疗胆总管结石后出血的预测模型:一项回顾性多中心研究。
JGH Open. 2020 May 17;4(5):915-922. doi: 10.1002/jgh3.12363. eCollection 2020 Oct.
10
Biliary endoscopic sphincterotomy: Techniques and complications.胆道内镜括约肌切开术:技术与并发症
World J Clin Cases. 2018 Dec 26;6(16):1073-1086. doi: 10.12998/wjcc.v6.i16.1073.

本文引用的文献

1
Factors associated with delayed hemorrhage after endoscopic sphincterotomy: Japanese large single-center experience.内镜下括约肌切开术后延迟性出血的相关因素:日本大型单中心经验。
J Gastroenterol. 2017 Dec;52(12):1258-1265. doi: 10.1007/s00535-017-1347-9. Epub 2017 May 6.
2
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation.心房颤动患者围手术期的桥接抗凝治疗
N Engl J Med. 2015 Aug 27;373(9):823-33. doi: 10.1056/NEJMoa1501035. Epub 2015 Jun 22.
3
Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment.抗栓治疗患者的胃肠内镜检查指南。
Dig Endosc. 2014 Jan;26(1):1-14. doi: 10.1111/den.12183. Epub 2013 Nov 12.
4
Feasibility of endoscopic retrograde cholangiopancreatography-related procedures in hemodialysis patients.血液透析患者行内镜逆行胰胆管造影相关操作的可行性
J Gastroenterol Hepatol. 2014 Mar;29(3):648-52. doi: 10.1111/jgh.12336.
5
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies.倾向得分法在观察性研究中减少混杂效应的介绍
Multivariate Behav Res. 2011 May;46(3):399-424. doi: 10.1080/00273171.2011.568786. Epub 2011 Jun 8.
6
Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study.内镜逆行胰胆管造影术后并发症的危险因素;一项大规模、前瞻性多中心研究的结果
Endoscopy. 2007 Sep;39(9):793-801. doi: 10.1055/s-2007-966723.
7
Incidence rates of post-ERCP complications: a systematic survey of prospective studies.内镜逆行胰胆管造影术后并发症的发生率:前瞻性研究的系统综述。
Am J Gastroenterol. 2007 Aug;102(8):1781-8. doi: 10.1111/j.1572-0241.2007.01279.x. Epub 2007 May 17.
8
ERCP core curriculum.内镜逆行胰胆管造影核心课程
Gastrointest Endosc. 2006 Mar;63(3):361-76. doi: 10.1016/j.gie.2006.01.010.
9
Evidence-based assessment: patient, procedure, or operator factors associated with ERCP complications.循证评估:与内镜逆行胰胆管造影术并发症相关的患者、操作或操作者因素。
Gastrointest Endosc. 2002 Dec;56(6 Suppl):S294-302. doi: 10.1067/mge.2002.129021.
10
[Cardiovascular risk in patients with chronic renal failure. Patients in renal replacement therapy].[慢性肾衰竭患者的心血管风险。接受肾脏替代治疗的患者]
Nefrologia. 2002;22 Suppl 1:68-74.